BioAge Labs (BIOA) Other Non-Current Assets (2023 - 2026)
BioAge Labs' (BIOA) quarterly Other Non-Current Assets came in at $215000.0 in Q1 2026, down 10.04% year-on-year from $239000.0 in Q1 2025, and little changed quarter-over-quarter from $216000.0 in Q4 2025.
BioAge Labs (BIOA) Other Non-Current Assets (2023 - 2026) Analysis & Trends
BioAge Labs has disclosed Other Non-Current Assets across 4 years of filings, most recently posting $215000.0 for Q1 2026.
- Other Non-Current Assets for Q1 2026 came in at $215000.0, down 10.04% year-over-year; the trailing twelve-month figure through Mar 2026 was $215000.0 (down 10.04% YoY), and the FY2025 annual result was $216000.0, down 10.0% from the prior year.
- Other Non-Current Assets came in at $215000.0 for Q1 2026 at BioAge Labs, roughly flat from $216000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $3.3 million in Q4 2023 to a low of $215000.0 in Q1 2026.
- The 4-year median for Other Non-Current Assets is $237000.0 (2025), against an average of $667714.3.
- Across the five-year window, Other Non-Current Assets slumped 92.73% in 2024 and retreated 10.0% in 2025, its largest moves.
- BioAge Labs' Other Non-Current Assets stood at $3.3 million in 2023, then plunged by 92.73% to $240000.0 in 2024, then slipped by 10.0% to $216000.0 in 2025, then decreased by 0.46% to $215000.0 in 2026.
- The last three Other Non-Current Assets figures came in at $215000.0 (Q1 2026), $216000.0 (Q4 2025), and $227000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1.79 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 351.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 233.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 73.60 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 295.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 59.36 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 47.63 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | BioAge Labs | 671.19 Mn | 288.00 Mn | -10.37 Mn | 215,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 215,000.00 |
| Dec 31, 2025 | 216,000.00 |
| Sep 30, 2025 | 227,000.00 |
| Jun 30, 2025 | 237,000.00 |
| Mar 31, 2025 | 239,000.00 |
| Dec 31, 2024 | 240,000.00 |
| Dec 31, 2023 | 3.30 Mn |